Thierry Passeron

14.0k total citations · 2 hit papers
281 papers, 7.1k citations indexed

About

Thierry Passeron is a scholar working on Dermatology, Cell Biology and Immunology. According to data from OpenAlex, Thierry Passeron has authored 281 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Dermatology, 119 papers in Cell Biology and 62 papers in Immunology. Recurrent topics in Thierry Passeron's work include melanin and skin pigmentation (112 papers), Skin Protection and Aging (87 papers) and Dermatologic Treatments and Research (45 papers). Thierry Passeron is often cited by papers focused on melanin and skin pigmentation (112 papers), Skin Protection and Aging (87 papers) and Dermatologic Treatments and Research (45 papers). Thierry Passeron collaborates with scholars based in France, United States and Germany. Thierry Passeron's co-authors include J.‐P. Lacour, Jean‐Paul Ortonne, Jean Krutmann, Éric Fontas, Vincent J. Hearing, Bruno Bernard, Anne Bouloc, Gabrielle Sore, Philippe Bahadoran and Henri Montaudié and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thierry Passeron

247 papers receiving 6.8k citations

Hit Papers

The skin aging exposome 2016 2026 2019 2022 2016 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The skin aging exposome
    2016 519 citations Jean Krutmann, Thierry Passeron et al. profile →
  2. Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
    2022 133 citations David Rosmarin, Thierry Passeron et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thierry Passeron 3.8k 3.1k 1.1k 1.1k 743 281 7.1k
Jin Ho Chung 4.4k 1.2× 2.0k 0.6× 2.4k 2.1× 696 0.6× 367 0.5× 274 9.1k
Mina Yaar 3.3k 0.9× 2.8k 0.9× 2.3k 2.1× 721 0.6× 594 0.8× 99 7.6k
Eugene Healy 2.0k 0.5× 1.8k 0.6× 1.6k 1.4× 745 0.7× 787 1.1× 112 5.5k
Iltefat Hamzavi 5.2k 1.4× 3.7k 1.2× 731 0.7× 1.3k 1.1× 888 1.2× 249 8.5k
Kowichi Jimbow 1.7k 0.5× 3.1k 1.0× 1.7k 1.5× 1.1k 1.0× 940 1.3× 216 5.7k
W. Westerhof 2.7k 0.7× 4.5k 1.4× 898 0.8× 1.7k 1.6× 996 1.3× 141 6.6k
Jean‐Paul Ortonne 3.4k 0.9× 4.5k 1.4× 2.6k 2.3× 2.9k 2.6× 1.3k 1.7× 140 9.9k
Kazunori Urabe 1.6k 0.4× 2.3k 0.7× 1.4k 1.2× 651 0.6× 1.4k 1.8× 130 4.5k
James J. Nordlund 2.5k 0.7× 4.4k 1.4× 1.6k 1.4× 1.6k 1.5× 1.5k 2.0× 168 7.2k
J.‐P. Ortonne 2.7k 0.7× 1.5k 0.5× 760 0.7× 1.7k 1.5× 289 0.4× 140 5.3k

Countries citing papers authored by Thierry Passeron

Since Specialization
Citations

This map shows the geographic impact of Thierry Passeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Passeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Passeron more than expected).

Fields of papers citing papers by Thierry Passeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Passeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Passeron. The network helps show where Thierry Passeron may publish in the future.

Co-authorship network of co-authors of Thierry Passeron

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Passeron. A scholar is included among the top collaborators of Thierry Passeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Passeron. Thierry Passeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sénéschal, Julien, et al.. (2025). Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo. JAMA Dermatology. 161(4). 375–375. 6 indexed citations
2.
Rosmarin, David, Amit G. Pandya, Thierry Passeron, et al.. (2025). Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo. Dermatology and Therapy. 15(12). 3703–3716.
3.
Zouboulis, Christos C., Thierry Passeron, David M. Pariser, et al.. (2024). Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials. British Journal of Dermatology. 190(6). 836–845. 10 indexed citations
4.
Kérob, Delphine, Thierry Passeron, Brigitte Dréno, et al.. (2024). 54736 Prevalence of solar lentigo, impact on quality of life and social stigmatization: Results of the first large international survey. Journal of the American Academy of Dermatology. 91(3). AB286–AB286.
5.
Passeron, Thierry, Brigitte Dréno, Susana Puig, et al.. (2024). Sun Exposure Behaviors and Knowledge Among the At‐Risk Population: Results From an International Survey, the HELIOS Project. Photodermatology Photoimmunology & Photomedicine. 40(6). 1 indexed citations
6.
Bzioueche, Hanene, M. Heim, Yann Chéli, et al.. (2024). CLEC12B Regulates Melanocyte Immunity and Homeostasis in the Skin through the Signal Transducer and Activator of Transcription 1/IRF1 Axis. Journal of Investigative Dermatology. 145(8). 2007–2020.e4.
7.
Passeron, Thierry, Éric Fontas, T. Boyé, et al.. (2024). Treatment of Bullous Pemphigoid with Avdoralimab: Multicenter, Randomized, Open-Labeled Phase 2 Study. SHILAP Revista de lepidopterología. 4(6). 100307–100307. 2 indexed citations
8.
Flament, Frédéric, Peggy Sextius, Yan Wang, et al.. (2024). A Bayesian network meta‐analysis of 14 molecules inhibiting UV daylight‐induced pigmentation. Journal of the European Academy of Dermatology and Venereology. 38(8). 1566–1574. 3 indexed citations
9.
Gilaberte, Yolanda, Jaime Piquero‐Casals, Sérgio Schalka, et al.. (2024). Exploring the impact of solar radiation on skin microbiome to develop improved photoprotection strategies. Photochemistry and Photobiology. 101(1). 38–52. 4 indexed citations
10.
11.
Lebwohl, Mark, Richard B. Warren, Howard Sofen, et al.. (2024). Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials. British Journal of Dermatology. 190(5). 668–679. 35 indexed citations
12.
Passeron, Thierry, Henry W. Lim, Chee Leok Goh, et al.. (2023). Sun exposure behaviours as a compromise to paradoxical injunctions: Insight from a worldwide survey. Journal of the European Academy of Dermatology and Venereology. 37(12). 2481–2489. 9 indexed citations
13.
Rodrigues, Michelle, Marwa Abdallah, Jung Min Bae, et al.. (2023). Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study. Journal of the American Academy of Dermatology. 89(2). 352–354. 1 indexed citations
14.
Passeron, Thierry, Brett King, Julien Sénéschal, et al.. (2023). Inhibition of T-cell activity in alopecia areata: recent developments and new directions. Frontiers in Immunology. 14. 1243556–1243556. 40 indexed citations
15.
Harris, John E., David Rosmarin, Julien Sénéschal, et al.. (2023). 43912 Facial Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies. Journal of the American Academy of Dermatology. 89(3). AB48–AB48. 1 indexed citations
16.
17.
Lebwohl, Mark, Richard B. Warren, Howard Sofen, et al.. (2023). Deucravacitinib long-term efficacy with continuous treatment in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine. 7(2). s118–s118. 3 indexed citations
18.
King, Brett, Arash Mostaghimi, Yutaka Shimomura, et al.. (2022). Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials. British Journal of Dermatology. 188(2). 218–227. 37 indexed citations
19.
Duteil, L., Catherine Queille‐Roussel, Carles Trullàs, et al.. (2022). Prevention of Polymorphic Light Eruption Afforded by a Very High Broad-Spectrum Protection Sunscreen Containing Ectoin. Dermatology and Therapy. 12(7). 1603–1613. 5 indexed citations
20.
Krutmann, Jean, Jaime Piquero‐Casals, D. Morgado‐Carrasco, et al.. (2022). Photoprotection for people with skin of colour: needs and strategies. British Journal of Dermatology. 188(2). 168–175. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin Ho Chung Breakdown of academic impact, for papers by Mina Yaar Breakdown of academic impact, for papers by Eugene Healy Breakdown of academic impact, for papers by Iltefat Hamzavi Breakdown of academic impact, for papers by Kowichi Jimbow Breakdown of academic impact, for papers by W. Westerhof Breakdown of academic impact, for papers by Jean‐Paul Ortonne Breakdown of academic impact, for papers by Kazunori Urabe Breakdown of academic impact, for papers by James J. Nordlund Breakdown of academic impact, for papers by J.‐P. Ortonne
Rankless by CCL
2026